Clinical Trials Browser

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Unknown Primary, Urogenital Neoplasms, Neoplasm, Residual

NCT07524803 2026-04-13

LUCAS-LATAM

Not yet recruiting

2,000 enrolled

Thoracic

Lung Neoplasms

NCT05952778 2026-04-09

Reminder Messages for Lung Cancer Screening

Active not recruiting

133 enrolled

Thoracic

Lung Neoplasms

NCT04849481 2026-04-08

The Research Plan of Taiwan Precision Medicine

Recruiting

550 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06181812 2026-04-08

Pathogenic Variants in Genes Associated With Lung Adenocarcinoma

Recruiting

332 enrolled

Thoracic

Adenocarcinoma of Lung

NCT07517393 2026-04-08

Study of Collection and Analysis of Clinical, Anamnestic, Functional, Biological Data Through the Support of Artificial Intelligence to Evaluate the Possibility of Defining a Digital Twin of the Lung (LUCE)

Recruiting

1,000 enrolled

Thoracic

Thoracic Neoplasms, Multiple Pulmonary Nodules

NCT05183932 2026-04-07

SORT

Active not recruiting

446 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05334069 2026-04-07

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Recruiting

2,000 enrolled

BreastDermatologicGastrointestinalGenitourinaryHead & NeckLymphoidMyeloidOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Esophageal Neoplasms, Lung Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07516015 2026-04-07

Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered NSCLC

Not yet recruiting

1,000 enrolled

Thoracic

NSCLC

NCT05387512 2026-04-06

Real-world Association Between Concomitant Beta-blocker Exposure and Anti-PD-1/PD-L1 Treatment Outcomes in Advanced Non-Small Cell Lung Cancer

Completed

60 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07511413 2026-04-06

GALENOS 1

Recruiting

110 enrolled

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Lung Neoplasms, Sarcopenia

NCT07510321 2026-04-03

FL-261 Imaging for Cancer Diagnosis and Staging

Recruiting

12 enrolled

GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms

NCT07510724 2026-04-03

IKF-ReWoLuTe

Recruiting

240 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms, Small Cell Lung Carcinoma

NCT07186699 2026-04-02

Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD

Recruiting

45 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07487883 2026-04-02

Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors

Recruiting

80 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Multiple Pulmonary Nodules

NCT05665504 2026-04-01

Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer

Recruiting

250 enrolled

Thoracic

Adenocarcinoma of Lung

NCT07498933 2026-04-01

FAP-targeted PET/NIR in Lung Malignant Tumors

Recruiting

200 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04881916 2026-03-30

Immune and Genomic Markers in ALK+ NSCLC

Active not recruiting

100 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07500376 2026-03-30

Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery

Recruiting

142 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Malnutrition, Sarcopenia

NCT05142033 2026-03-27

ASAP

Recruiting

25,000 enrolled

BreastCNSGastrointestinalGynecologicOther hematologic neoplasmThoracic

Breast Neoplasms, Colonic Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Central Nervous System Neoplasms, Endometrial Neoplasms, Hematologic Neoplasms

NCT06132607 2026-03-27